EATG » Hepatitis

Hepatitis

Eliminating Hepatitis: A unique opportunity that shouldn’t be missed

EU policymakers owe it to Europe’s citizens to make hepatitis a thing of the past, argues Tatjana Reic. Hepatitis C (HCV) is an urgent public health problem for the European…

Eastern Europe and Central Asia adopt statement on fighting infectious diseases

MINSK, 22 November (BelTA) – The international statement on expanding access to affordable and quality assured medicines and diagnostics will help coordinate efforts of Eastern Europe and Central Asia (EECA)…

PHE and NHSE launch national drive to trace hepatitis C patients

Public Health England and NHS England are working to find thousands of people living with hep C, offering them new treatments that, in most cases, cure the illness. Public Health…

Belarus to increase purchase of hepatitis C drugs twofold

Belarus will increase the purchase of modern medications to treat hepatitis C twofold, Belarus' Healthcare Minister Valery Malashko told reporters, BelTA has learned. “In 2017 alone, we used the latest…

US: Targeted hepatitis C testing misses substantial number of cases in correctional setting

Researchers recommend routine testing for all incarcerated individuals upon arrival BOSTON— Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant…

Screening for hepatitis B and hepatitis C: benefit unclear due to a lack of suitable studies

Risk-group screening for hepatitis C requires thorough accompanying evaluation Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing…

New research aims to help improve uptake of hepatitis C testing

New research published in Scientific Reports shows persisting fears about HIV infection may impact testing uptake for the Hepatitis C Virus (HCV). HCV infects the liver. If left untreated, it can cause…

In older hep B patients, carcinoma surveillance is advised

SAN FRANCISCO — Surveillance for hepatocellular carcinoma (HCC) should continue in patients older than 50 years, even after they have undergone 5 years of therapy for chronic hepatitis B, according to…

Hepatitis C-infected organs deemed safe for transplant

SAN FRANCISCO — Direct-acting antiviral medications can make the transplantation of organs infected with hepatitis C safe for recipients who do not have the virus, new research shows. This finding…

DAA treatment and hepatic fibrosis improvement in HCV: What’s the link?

According to the results of a prospective cohort study, 57% of patients with hepatitis C virus (HCV) infection who achieved sustained virologic response (SVR) showed no improvement in hepatic fibrosis.…

1 3 4 5 6 7 98